COVID-19 Vaccine
 

COVID-19 Vaccine Eligibility Criteria


All people in Manitoba aged 6 months and older are eligible for COVID-19 vaccination. This page provides information about vaccine eligibility and recommendations on the type of vaccine people should receive. If you have questions about your individual circumstances, including your individual risks and benefits of vaccination, please speak with your health care provider.

Canada's National Advisory Committee on Immunization (NACI) makes COVID-19 vaccine specific recommendations for people of all ages. These recommendations and guidance from NACI are available here.


On this page


Other important information

You can make your vaccine appointment at some sites online or by calling 1-844-626-8222. The vaccine is also available from medical clinics, pharmacies and other locations. Use the Vaccine Finder to find a convenient location.

It's helpful to know when you received your previous doses of COVID-19 vaccine and the type of vaccine you received. If you do not recall this information and you have a Manitoba health card, you can locate it at: sharedhealthmb.ca/covid19/test-results/. If your immunization record is incomplete or incorrect, or you received a COVID-19 vaccination outside of Manitoba, you can have your file updated by completing and submitting this e-form.

You will need to complete a consent form for every COVID-19 vaccine you receive. Filling out the form in advance can make it faster for you to get your vaccine. Click here to fill out and print your consent form.




Children aged 6 months to 4 years


All children in this age group are eligible to receive a primary COVID-19 vaccine series of Moderna vaccine. A primary series consists of two doses. Booster doses are not available for this age group at this time.

Children must be at least six months of age at the time of their immunization appointment.

The interval between first and second doses for most children is eight weeks. Parents/guardians who want their child to receive their second dose sooner (after 28 days but before eight weeks) should discuss the risks and benefits with their immunizer or health care provider before vaccination, to ensure the parent/guardian understands the risks of an earlier second dose. A longer time period between doses provides a stronger immune response.

For more information on NACI recommendations, please go to the Canadian Immunization Guide.




Children aged 5 to 11


Children in this age group are eligible to receive a primary COVID-19 vaccine series of a pediatric Pfizer or Moderna vaccine. A primary series consists of two doses. Booster doses are not available for this age group at this time.

Children must be five years old at the time of their immunization appointment. The interval between first and second doses for most children is eight weeks. Parents/guardians who want their child to receive their second dose sooner (after 21 days but before eight weeks) should discuss the risks and benefits with their immunizer or health care provider before vaccination, to ensure the parent/guardian understands the risks of an earlier second dose. A longer time period between doses provides a stronger immune response.

For children living in First Nations communities, the recommended interval is 21 days for the pediatric Pfizer vaccine and 28 days for the Moderna vaccine.

Children who are 5 years old and before their sixth birthday are only authorized to receive the pediatric Pfizer vaccine. Children who are between 6 and 11 years of age can receive either the pediatric Pfizer vaccine or the Moderna vaccine. The National Advisory Committee on Immunization (NACI) recommends the use of Pfizer vaccine for children 5 to 11 years of age because there is more data available from the real-world use of this vaccine. For more information on NACIs recommendations, please see COVID:19 vaccine: Canadian Immunization Guide.




Youth aged 12 to 17


Youth in this age group are eligible to receive a primary COVID-19 vaccine series and a first booster dose. A primary series consists of two doses of an mRNA COVID-19 vaccine.

The interval between first and second dose is eight weeks. Individuals who wish to receive their second dose sooner (after 28 days but before eight weeks) should discuss the risks and benefits with their immunizer or health care provider before vaccination, to ensure they understand the risks of an earlier second dose. A longer time period between doses provides a stronger immune response.

The National Advisory Committee on Immunization (NACI) recommends a first booster dose for adolescents at increased risk of severe illness from COVID-19. For more information on NACIs recommendations, please see COVID-19 vaccine: Canadian Immunization Guide.

The timeline to receive a first booster dose is at least four months after the last dose in the primary series.

Youth aged 12 to 17 are recommended to receive the Pfizer vaccine for all doses, due to a lower risk of myocarditis/pericarditis with this vaccine as compared to the Moderna vaccine in this age group.




Adults aged 18 years and older


All adults aged 18 and older are eligible to receive a primary COVID-19 vaccine series and a first booster dose. Some adults who are at increased risk of severe illness from COVID-19 are also eligible to receive a second booster dose.

A primary series consists of two doses. The interval between the first and second dose is 8 weeks. Individuals who wish to receive their second dose sooner (after 28 days but before eight weeks) should discuss the risks and benefits with their immunizer or health care provider before vaccination, to ensure they understand the risks of an earlier second dose. A longer time period between doses provides a stronger immune response.

The timeline to receive a first booster dose is at least four months after the last dose in the primary series.


The following individuals are eligible to receive a second booster dose of COVID-19 vaccine:

  • residents of personal care homes and elderly persons housing congregate living sites (such as supportive housing and assisted living) with no age limit;
  • individuals aged 50 or older who live in the community;
  • First Nations, Inuit and Metis people aged 30 or older, regardless of where they live, and
  • individuals 18 to 49 years of age who are moderately to severely immunocompromised.
    For individuals 18 to 49 years of age who are moderately to severely immunocompromised who are uncertain about whether to receive a second booster or when to receive one, please discuss your options with your health care provider.

The National Advisory Committee on Immunizations (NACI) recommends a second booster dose for some adults at increased risk. For more information on NACIs recommendations, please see COVID-19 vaccine: Canadian Immunization Guide.

The second booster dose should be given at least four months after the first booster dose.

For booster doses, either mRNA vaccine (Pfizer or Moderna) can be given, regardless of the COVID-19 vaccines previously given.

Adults under the age of 30 are recommended to receive Pfizer for all doses, due to a lower risk of myocarditis/pericarditis with this vaccine as compared to Moderna in this age group.

Adults aged 30 years and older can get either mRNA vaccine (Pfizer or Moderna).


For the primary series, it is recommended to get the same mRNA vaccine, if available. However, getting a combination of mRNA vaccines is both safe and effective, and either (Pfizer or Moderna) can be offered if:

  • the same mRNA vaccine is not available,
  • your previous dose was with a non-mRNA vaccine (e.g. AstraZeneca, Janssen), or
  • the last dose is unknown.



Infants, Children, Youth and Adults who are Moderately to Severely Immunocompromised


For the purposes of COVID-19 vaccine recommendations, the following individuals are considered moderately to severely immunocompromised due to a medical condition and/or treatment:

  • are receiving active chemotherapy (or immunotherapy) for cancer;
  • have received a solid organ transplant and are currently receiving chemotherapy or other immunosuppressive therapy;
  • were born with moderate or severe dysfunction of their immune system;
  • are living with untreated or advanced HIV-AIDS; or
  • are taking certain medications that severely affect the immune system.

The following people should talk to their doctor to see whether they are considered to be immunocompromised:

  • receiving hemodialysis or peritoneal dialysis;
  • are on the list to receive a solid organ transplant; or
  • have a ventricular assist device (VAD).

Infants, children, youth and adults who are moderately to severely immunocompromised are recommended to receive a primary series of COVID-19 vaccine that consists of three doses. The interval between the first and the second dose is 8 weeks. Individuals who wish to receive their second dose sooner (after 28 days but before eight weeks) should discuss the risks and benefits with their immunizer or health care provider before vaccination, to ensure they understand the risks of an earlier second dose. A longer time period between doses provides a stronger immune response. The third dose in the primary series requires a prescription if given outside of a physician or pharmacists office and must be given at least 28 days after the second dose.

Youth and adults 12 years of age and older are eligible to receive a first booster dose. For moderately to severely immunocompromised people, the first booster dose would be their fourth dose. The interval between the third dose in the primary series and the first booster dose is at least 4 months. Refer to the appropriate section above for more information on first booster doses for youth and adults.

Some adults 18 years of age and older are eligible to receive a second booster dose (as indicated in the above section for adults aged 18 years and older). For moderately to severely immunocompromised people, the second booster dose would be their fifth dose. The interval between the first booster and the second booster dose is at least 4 months.




Immunization after a COVID-19 infection


It is possible that people will get COVID-19 before getting their COVID-19 vaccine. At the very least, people need to wait until they have fully recovered and completed their isolation period before getting their next dose. Public health recommends the following intervals between infection and getting the vaccine:

  • two months if you have not completed a two-dose primary series
  • three months if you have completed your primary series and eligible for a booster dose.

Recommendations may be different if you are moderately to severely immunocompromised. Please speak to your health care provider to get the best advice on when to get your next vaccine dose after a COVID-19 infection.

For more information on NACI's recommendation on interval between infection and getting your next COVID-19 vaccine dose, please visit: COVID-19 vaccine: Canadian Immunization Guide - Canada.ca.